Article
A novel tubulin binding molecule drives differentiation of acute myeloid leukaemia cells
2021-06-03
Abstract excerpt
Acute Myeloid Leukaemia (AML) continues to have a poor prognosis, especially in the elderly. One reason for this is that many treatment regimens are not well tolerated by elderly patients. Much current focus is on the development of therapies that can target specific vulnerabilities of AML while having fewer toxic side effects. However, despite much recent progress in developing better drugs, many patients with AM...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5aa19c5e-a3c6-5d92-bf0b-82aebf2f179b
- DOI
- 10.1101/2021.06.03.446952
